Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK | BSE: 532296
Strong Performer, Getting Expensive
In 2 Starfolio Baskets
Download real time
2030.10
20.40
(
1.02
%)
59.16% Gain from 52W Low
817.8K
NSE+BSE Volume
NSE
30 Dec, 2025 2:35 PM (IST)
Watchlist
Portfolio
Alert
My Notes
TRADE STOCK
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharma - GLENMARK, 532296 corporate action history
Check all corporate actions such as stock splits, bonuses, dividends, mergers & acquisitions, rights issues & board meeting announcements for Glenmark Pharma
GET EVENTS ALERTS
LIVE SAMPLE
Daily Digest
Bonus history for Glenmark Pharma
Glenmark Pharma has given 1 bonus since March 4, 2005. The last Bonus that Glenmark Pharma anoununced was in the ratio 1:1 with ex-date of March 4, 2005.
Ex-Date
Bonus Ratio
Record Date
04 Mar 2005
1:1
-
See all forthcoming Bonus and split
Split history for Glenmark Pharma
Glenmark Pharma has split the face value 2 times since Oct. 23, 2003. Glenmark Pharma had last split the face value of its shares from ₹2 to ₹1 in 2007.The share has been quoting on an ex-split basis from Sept. 10, 2007.
Ex-Date
Old FV
New FV
Record Date
10 Sep 2007
2
1
-
23 Oct 2003
10
2
31 Oct 2003
See all forthcoming Bonus and split
Dividend history for Glenmark Pharma
Glenmark Pharma has declared 26 dividends since Sept. 3, 2001.
In the past 12 months, Glenmark Pharma has declared an equity dividend amounting to ₹5.00 per share.
At the current share price of ₹2030.1000, Glenmark Pharma's dividend yield is 0.25%.
Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
03 Oct 2025
2.50
INTERIM
03 Oct 2025
Equity Share
15 Sep 2025
2.50
FINAL
15 Sep 2025
Equity Share
13 Sep 2024
2.50
FINAL
-
Equity Share
18 Sep 2023
2.50
FINAL
-
Equity Share
12 Sep 2022
2.50
FINAL
-
Equity Share
08 Sep 2021
2.50
FINAL
-
Equity Share
17 Sep 2020
2.50
FINAL
-
Equity Share
19 Sep 2019
2.00
FINAL
-
Equity Share
19 Sep 2018
2.00
FINAL
-
Equity Share
20 Sep 2017
2.00
FINAL
-
Equity Share
03 Aug 2016
2.00
FINAL
-
Equity Share
10 Sep 2015
2.00
FINAL
-
Equity Share
10 Jul 2014
2.00
FINAL
-
Equity Share
18 Jul 2013
2.00
FINAL
-
Equity Share
19 Jul 2012
2.00
FINAL
-
Equity Share
28 Jul 2011
0.40
FINAL
-
Equity Share
16 Sep 2010
0.40
FINAL
-
Equity Share
10 Sep 2009
0.40
FINAL
-
Equity Share
07 Nov 2007
0.70
INTERIM
08 Nov 2007
Equity Share
04 Jan 2007
0.80
INTERIM
05 Jan 2007
Equity Share
07 Feb 2006
0.70
INTERIM
09 Feb 2006
Equity Share
29 Apr 2005
0.70
INTERIM
02 May 2005
Equity Share
31 Mar 2004
1.30
INTERIM
03 Apr 2004
Equity Share
10 Jun 2003
6.50
INTERIM
-
Equity Share
12 Sep 2002
6.00
FINAL
-
Equity Share
03 Sep 2001
4.00
FINAL
-
Equity Share
VIEW MORE
See all forthcoming dividends
Check out stocks with top dividend.
Board Meetings - Glenmark Pharma
The latest board meeting for Glenmark Pharma took place on 14 Nov 2025, for the purpose of Quarterly Results
Ex-Date
Purpose
Notes
14 Nov 2025
Quarterly Results
-
26 Sep 2025
Interim Dividend
-
14 Aug 2025
Quarterly Results
-
23 May 2025
Audited Results & Final Dividend
-
14 Feb 2025
Quarterly Results
-
14 Nov 2024
Quarterly Results
-
14 Aug 2024
Quarterly Results
-
24 May 2024
Audited Results & Final Dividend
-
14 Feb 2024
Quarterly Results
-
10 Nov 2023
Quarterly Results
-
See all Board Meetings for Glenmark Pharma
Glenmark Pharma Rights history
Glenmark Pharma has not issued
any
rights since Jan 1, 2000.
See all Rights History for Glenmark Pharma
